OrthoPediatrics Corp.
NASDAQ:KIDSMedical - Devices
+$0.19 today
- Market cap
- $826.40M
- Beta
- 1.01
- P/E (TTM)
- -11.0
- EPS (TTM)
- -$1.68
Volume 0.16M
Average 0.16M
KIDS Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
OrthoPediatrics Corp.NASDAQ: KIDS
Accounts Payables · Q1 FY2026 · quarter ended Mar 2026
Accounts payables dips below year-ago levels
Q1 FY2026 accounts payables of $704K fell 86.5% year over year, behind the +165.0% change in trailing-twelve-month accounts payables. Sequentially, it fell 93.0% from the prior quarter.
Context
- Accounts payables amounted to 3.5% of revenue in FY2025, up 1.4 pp from a year earlier.
- Accounts payables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -86.5% toward the trailing-twelve-month pace of +165.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 8.17M USD
- Year-over-year change
- +290.8%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.17M | +290.8% |
| FY2024 | 2024-12-31 | (4.28M) | -387.1% |
| FY2023 | 2023-12-31 | 1.49M | +813.4% |
| FY2022 | 2022-12-31 | (209K) | +63.1% |
| FY2021 | 2021-12-31 | (567K) | — |
Accounts Payables vs competitors
How KIDS compares with its peers on the latest reported figures
- KIDS's LTM Mar 2026 accounts payables of $3.66M is the 3rd largest of the 8 companies compared; the peer median is $22K.
- Its year-over-year change of +165.0% is the highest of 8, against a peer median of -62.2%.
- Accounts payables amounts to 1.5% of revenue for KIDS, versus a peer median of 0.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $19.19M | +142.5% | — | 3.5% | |
| LTM Mar 2026 | $8.06M | -62.2% | — | 1.4% | |
| LTM Mar 2026 | $3.66M | +165.0% | — | 1.5% | |
| LTM Mar 2026 | $2.23M | -153.0% | +118.5% | 0.7% | |
| LTM Mar 2026 | $571K | -82.0% | — | 0.7% | |
CBLLCeriBell, Inc. | LTM Mar 2026 | $543K | +86.6% | +141.4% | 0.6% |
| LTM Mar 2026 | $314K | +104.0% | — | 0.2% | |
| LTM Mar 2026 | $22K | -101.1% | -0.4% | 0.0% | |
| Peer median (excluding KIDS) | $22K | -62.2% | +118.5% | 0.7% | |
Competitors are the stored peer set for KIDS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (16.26M) | 1.26M | (20.97M) | (37.82M) | (39.65M) |
| Depreciation & Amortization | 10.68M | 13.1M | 17.39M | 19.08M | 21.12M |
| Deferred Income Tax | (1.13M) | (5.03M) | (1.16M) | (4.74M) | (153K) |
| Stock-Based Compensation | 5.84M | 6.68M | 10.53M | 13.55M | 17.78M |
| Change in Working Capital | (12.55M) | (17.76M) | (32.2M) | (22.94M) | (10.79M) |
| Accounts Receivables | (466K) | (3.98M) | (9.72M) | (4.75M) | (9.37M) |
| Inventory | (5.05M) | (16.94M) | (26.28M) | (13.2M) | (8.47M) |
| Accounts Payables | (567K) | (209K) | 1.49M | (4.28M) | 8.17M |
| Other Working Capital | (6.47M) | 3.37M | 2.32M | (709K) | (1.12M) |
| Other Non-Cash Items | 354K | (20.01M) | (623K) | 5.82M | 6.85M |
| Operating Cash Flow | (13.06M) | (21.77M) | (27.05M) | (27.05M) | (4.85M) |
| Capital Expenditures | (16.01M) | (10.03M) | (18.98M) | (14.26M) | (11.11M) |
| Acquisitions (Net) | 0 | (40.09M) | (3.64M) | (20.23M) | (15.5M) |
| Purchases of Investments | 0 | (110.12M) | (48.6M) | (25.65M) | (17.02M) |
| Sales of Investments | 9.25M | 46.87M | 112.9M | 49.86M | 0 |
| Other Investing Activities | (650K) | 0 | (2.11M) | (2.88M) | 0 |
| Investing Cash Flow | (7.41M) | (113.37M) | 41.68M | (13.16M) | (43.63M) |
| Debt Repayment | (131K) | (137K) | 9.28M | 56.54M | 23.98M |
| Common Stock Issued | 137K | 139.28M | 21K | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (3.17M) | (2M) | (3.41M) | 0 |
| Financing Cash Flow | 6K | 135.97M | 7.3M | 53.14M | 23.98M |
| Effect of Forex Changes | (658K) | 619K | 633K | (175K) | 348K |
| Net Change in Cash | (21.13M) | 1.46M | 22.57M | 12.75M | (24.16M) |
| Free Cash Flow | (29.07M) | (31.8M) | (46.03M) | (41.31M) | (15.96M) |
OrthoPediatrics Corp.
NASDAQ:KIDS
Intrinsic Alpha fair value
Locked
Current Price
$31.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.